Proximagen Neuroscience Share Discussion Threads

[haroldthegreat] 02/9/2021 08:37

I used prosy and nothing appeared !

[haroldthegreat] 02/9/2021 08:30

Thank you Tim . I used the wrong code ! Why no price on left side of chart ?

[elgordo] 01/4/2016 21:49

For my own reference more than anything else -



Most Recent Events

15 Feb 2016 Phase-II development in Osteoarthritis is ongoing in United Kingdom (PO)
01 Dec 2015 PRX 167700 licensed to Roche worldwide
19 Jul 2013 Phase-II clinical trials in Osteoarthritis in United Kingdom (PO)

[elgordo] 22/7/2015 14:35

In case anyone out there is interested...

I have just got hold of the CVR Representative’;s annual update for 2014, issued in March 2015. (These updates are supposed to be issued to holders annually, but I had not seen previous ones and had considerable trouble getting hold of this one – maybe that’s just a problem I’m having?)

In summary, the potential value from the CVRs was derived from two programmes, and their status is as follows:

PRX00993 – dead and buried (“discontinued”).

PRX-167700 – Active partnering discussions on back of progress and headline results of Phase IIa osteoarthritis study and planning for IBD clinical studies. “In January 2015 a potential partner proposed terms for supporting Phase II clinical study with an option for commercial rights. Discussions are continuing with this potential partner as well as other potential partners.”

So, still some hope of value to be derived from the CVRs, though I believe they expire at the end of August 2017 so time is starting to run quite short.

[elgordo] 09/8/2012 13:17

Farewell then, Proximagen. I decided to hold on for the CVRs - any value that comes through from them will be a nice bonus down the line.

[mike111d] 19/6/2012 18:46

I have always rated the management here, a sound investment IMO.

[elgordo] 19/6/2012 13:15

A great result. Any other holders out there with thoughts on whether better to sell into the market, or take the 320p and the CVRs? Should have a good few weeks to decide, and the implied value of the CVRs appears to be creeping upwards... I'm minded to gamble that Upsher-Smith's confidence in acquiring the VAP-1 and PRX00933 programs will convert into successful commercialisation down the line, but if the share price moves up further there will be a point where it becomes clearly better to take the money now. What I have no way of assessing is where that point lies.

[pugg1ey] 14/6/2012 07:59

yep. nothing like insider info :-)

[charmer1_23] 13/6/2012 07:44

LOL, now we know why these had been rising sharply recently, held these a few years back under a quid I think, doh!

[pugg1ey] 14/5/2012 10:05

I sold out at 180p and thought I had banked a nice profit ;-)

If locaserin gets the nod this increases the value of PRX's own 5-HT2c program which is in phase 2 and looking to go to phase 3?

[charmer1_23] 14/5/2012 09:58

What's the story here then folks, shares have taken off sharply in the last few trading sessions but little discussion here. Regards :=)

[thedickster] 05/3/2012 11:10

Boom, i'm in SCLP post that post, many thanks for this

[pugg1ey] 01/2/2012 15:59

lol. not surprised noone interested in such an illiquid stock but chance of a takeover here, maybe?

[pugg1ey] 01/2/2012 12:15

mms moving up on just a 2K buy

[pugg1ey] 26/1/2012 16:37

bought some just before the close. something going on here(in a good way for the SP) imo

[elgordo] 24/1/2012 18:33

Up over 11% today, with around 9% of the company changing hands, and no comment? Just how under the radar is this?

[mike111d] 22/12/2010 12:27

Yes well done to the BOD, another good year for PRX.

[bobt5940] 06/1/2010 17:21

ElGordo: Will you wake me up when there`s any news?.......Zzzzzzzzz!